Your session is about to expire
← Back to Search
JAK/T-cell/IL-6 for Rheumatoid Arthritis (PREDICT Trial)
N/A
Recruiting
Research Sponsored by Scipher Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
PREDICT Trial Summary
Prospective, multi-center-observational study conducted within the US, collecting patient samples for research and development to train, test, and validate precision medicine classifiers. These molecular signature response classifiers (MSRC) aim to predict response status to JAK, T-cell, and IL-6 inhibitor therapies in patients with rheumatoid arthritis (RA).
Eligible Conditions
- Rheumatoid Arthritis
PREDICT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The rate of MSRC to predict the patients response
PREDICT Trial Design
1Treatment groups
Experimental Treatment
Group I: JAK/T-cell/IL-6Experimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Scipher MedicineLead Sponsor
1 Previous Clinical Trials
613 Total Patients Enrolled
1 Trials studying Rheumatoid Arthritis
613 Patients Enrolled for Rheumatoid Arthritis
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger